These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 26056441)
1. Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles. Wang B; Tan L; Deng D; Lu T; Zhou C; Li Z; Tang Z; Wu Z; Tang H Int J Nanomedicine; 2015; 10():3417-27. PubMed ID: 26056441 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2. Wang B; Guo Y; Chen X; Zeng C; Hu Q; Yin W; Li W; Xie H; Zhang B; Huang X; Yu F Int J Nanomedicine; 2018; 13():7395-7408. PubMed ID: 30519022 [TBL] [Abstract][Full Text] [Related]
3. Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds. Tan Q; Tang H; Hu J; Hu Y; Zhou X; Tao Y; Wu Z Int J Nanomedicine; 2011; 6():929-42. PubMed ID: 21720505 [TBL] [Abstract][Full Text] [Related]
4. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid. Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490 [TBL] [Abstract][Full Text] [Related]
5. Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles. Zaman P; Wang J; Blau A; Wang W; Li T; Kohane DS; Loscalzo J; Zhang YY Int J Nanomedicine; 2016; 11():6149-6159. PubMed ID: 27920522 [TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor-1α-encapsulated albumin/heparin nanoparticles for induced stem cell migration and intervertebral disc regeneration in vivo. Zhang H; Yu S; Zhao X; Mao Z; Gao C Acta Biomater; 2018 May; 72():217-227. PubMed ID: 29597025 [TBL] [Abstract][Full Text] [Related]
7. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557 [TBL] [Abstract][Full Text] [Related]
8. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700 [TBL] [Abstract][Full Text] [Related]
9. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles. Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652 [TBL] [Abstract][Full Text] [Related]
10. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. Liu Z; Jiao Y; Liu F; Zhang Z J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117 [TBL] [Abstract][Full Text] [Related]
11. In situ controlled release of stromal cell-derived factor-1α and antimiR-138 for on-demand cranial bone regeneration. Wu G; Feng C; Quan J; Wang Z; Wei W; Zang S; Kang S; Hui G; Chen X; Wang Q Carbohydr Polym; 2018 Feb; 182():215-224. PubMed ID: 29279118 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast-derived matrix (FDM) as a novel vascular endothelial growth factor delivery platform. Du P; Hwang MP; Noh YK; Subbiah R; Kim IG; Bae SE; Park K J Control Release; 2014 Nov; 194():122-9. PubMed ID: 25194780 [TBL] [Abstract][Full Text] [Related]
13. Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells. Du YZ; Wang L; Yuan H; Hu FQ Int J Biol Macromol; 2011 Jan; 48(1):215-22. PubMed ID: 21093477 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of SDF-1α-chitosan-dextran sulfate nanoparticles. Bader AR; Li T; Wang W; Kohane DS; Loscalzo J; Zhang YY J Vis Exp; 2015 Jan; (95):52323. PubMed ID: 25650558 [TBL] [Abstract][Full Text] [Related]
15. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation. Shahbazi MA; Hamidi M; Mohammadi-Samani S J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580 [TBL] [Abstract][Full Text] [Related]
16. Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles. Huang YC; Liu TJ Acta Biomater; 2012 Mar; 8(3):1048-56. PubMed ID: 22200609 [TBL] [Abstract][Full Text] [Related]
17. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531 [TBL] [Abstract][Full Text] [Related]
18. Injectable nanoparticles/hydrogels composite as sustained release system with stromal cell-derived factor-1α for calvarial bone regeneration. Mi L; Liu H; Gao Y; Miao H; Ruan J Int J Biol Macromol; 2017 Aug; 101():341-347. PubMed ID: 28330754 [TBL] [Abstract][Full Text] [Related]
19. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809 [TBL] [Abstract][Full Text] [Related]
20. Entrapment of basic fibroblast growth factor (bFGF) in a succinylated chitosan nanoparticle delivery system and release profile. Butko A; Bonat Celli G; Paulson A; Ghanem A J Biomater Sci Polym Ed; 2016 Jul; 27(10):1045-57. PubMed ID: 27146359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]